Products for Research Use Only
RegisterLogin

ETP-46321

CAT: 0804-HY-12340-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12340-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
ETP-46321 is a potent and orally bioavailable PI3Kα and PI3Kδ inhibitor with Kiapps of 2.3 and 14.2 nM, respectively.
CAS Number
1252594-99-2
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
PI3K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/etp-46321.html
Purity
99.34
Solubility
DMSO : ≥ 33 mg/mL
Smiles
NC(N=C1)=NC=C1C2=CN3C=C(CN4CCN(S(=O)(C)=O)CC4)N=C3C(N5CCOCC5)=N2
Molecular Formula
C20H27N9O3S
Molecular Weight
473.55
Precautions
H302, H315, H319, H335
References & Citations
[1]Martínez González S, et al. Identification of ETP-46321, a potent and orally bioavailable PI3K α, δ inhibitor. Bioorg Med Chem Lett. 2012 May 15;22 (10) :3460-6.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI3Kα; PI3Kβ; PI3Kγ; PI3Kδ

Related Products

CatalogName
HY-110109-01ETP-45658
HY-15521-01ETP-46464
HY-139810ETP-47037
HY-W846144ETP-45835
HY-110336ETP-45835 (dihydrochloride)
HY-RI01173-01Hsa-miR-4632-5p inhibitor
HY-RI01172-01Hsa-miR-4632-3p inhibitor
HY-RI01173A-01Hsa-miR-4632-5p antagomir
HY-RI01172A-01Hsa-miR-4632-3p antagomir
HY-R01172-01Hsa-miR-4632-3p mimic

Alternative Products

CatalogName
MBS131660-01ETP-46321
A16271-50ETP-46321 50mg
A16271-25ETP-46321 25mg
A16271-200ETP-46321 200mg
A16271-10ETP-46321 10mg
A16271-100ETP-46321 100mg
A16271-5ETP-46321 5mg
A16271-1ETP-46321 1mg
A16271-10mM-DETP-46321 10mM * 1mL in DMSO
BA3951-5ETP-45658

Popular Products